Hidradenitis
Not recruitingStudy of Tibulizumab to Treat Adults with Hidradenitis Suppurativa
- Disease:Hidradenitis
- Substances:–
Germany- Participants:18–64 years · 65+ years
- Sponsor:Zura Bio Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany2 clinical trials in Bad Bendheim, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on Chronic Spontaneous Urticaria (CSU), evaluating long-term treatment outcomes and patient response patterns. The research aims to advance understanding of sustained therapeutic benefits in chronic skin conditions.
This extended research program examines the effectiveness of remibrutinib treatment, focusing on maintaining disease control and preventing symptom relapse in patients with chronic urticaria.
Tell us about your condition – we search every trial in Europe and connect you with the right site.